July/August 2021 • PharmaTimes Magazine • 3


From the editor

Whilst we have seen the COVID pandemic wreak havoc on care pathways across the country, it has also spurred closer and more concentrated working relationships between all factions of healthcare, with the common goal of improving outcomes for patients. And so learnings from this year’s Patient Partnership Index (p20) should be more pertinent now than ever before, helping pharma to keep patients at the centre of all that it does amid these particularly challenging times. A huge congratulations to Gilead Sciences, Leo Pharma (UK) and Pfizer, which all achieved GOLD standard for their entries.

Also with patients firmly in mind, on page 17 John Pinching considers how a growing confidence in the life sciences industry and the currency of individual experience is giving patient centricity an injection of new life, while on page 24 Oli Hudson outlines six different ways the industry has partnered with the NHS, all mutually beneficial while ultimately improving services for patients.

Elsewhere, David Sant provides fascinating insight into the debate over patent waivers for COVID vaccines and technology (p34), while Chris Smith, Robin Ellis and Pete Sadler urge pharma companies to be prepared for standard-essential patents, which are coming to the industry in one way or another (p32).

Finally, another reminder that the 2021 PharmaTimes Marketer of the Year, Communications Awards and Sales Awards are open for entry, while tickets are still on sale for the International Clinical Researcher of the Year gala dinner. For more information visit www.pharmatimes.com/competitions

I hope you enjoy the issue!

Image

Selina McKee
editor

Image

PharmaTimes Media Ltd,
Mansard House, Church Road,
Little Bookham, Surrey, KT23 3JG
Tel: +44 (0)20 7240 6999
www.pharmatimes.com Twitter: @PharmaTimes

EDITORIAL
Selina McKee / editor
selina.mckee@pharmatimes.com
Karl Equi / executive director
karl.equi@pharmatimes.com   

SALES & MARKETING
Tara Lovegrove / business director
tara.lovegrove@pharmatimes.com
Elliott Skilton / marketing executive
elliott.skilton@pharmatimes.com

SUBSCRIPTIONS/REPRINTS
Digital and paper copies available free to qualifying readers: www.pharmatimes.com/subscribe
Tel: 01372 414 222
subscriptions@pharmatimes.com
Paper subscriptions available at £90.00 UK and £100.00 overseas per annum.

Views expressed by the contributors do not necessarily represent those of the publisher, editor or staff.

Material may not be reproduced in any form without the publisher’s written permission. © Copyright 2021 PharmaTimes Magazine. All rights reserved. PharmaTimes Magazine is published by PharmaTimes Media Ltd, which is registered as a limited company in England; No 09019637.

IN THE PIPELINE:

SEPTEMBER: Diversity and inclusion in pharma and healthcare. Are we making progress?

OCTOBER: Manufacturing innovations and climate change. How can advances help reduce pharma’s carbon footprint?


You can help shape these articles. For more information, please email tara.lovegrove@pharmatimes.com